Loading...
NPI 1164094108 · Honolulu, HI · Diagnostic Radiology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Honolulu Imaging Center, LLC is a diagnostic radiology physician provider located in Honolulu, Hawaii. This profile covers 58 Medicare and 11 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Honolulu Imaging Center, LLC |
| Address | 1401 S Beretania St Ste 107 |
| City | Honolulu |
| State | HI |
| ZIP | 96814 |
| Taxonomy | Diagnostic Radiology Physician |
| NPI Enumerated | July 10, 2021 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.6M |
| Medicaid | $1.1M |
Specialty service mix is heavily weighted to advanced PET imaging and radiopharmaceuticals: Medicare top codes are A9596 (1.2K claims, $968.6K revenue), 78815 (585 claims, $783.3K revenue) and A9552 (474 claims, $203.3K revenue), and these CPT/HCPCS descriptions indicate PET/CT studies and radiotracer doses as the core service lines. The presence of multiple MRI codes in the top Medicare list (e.g., 70553, 72148, 73221) shows the operation also provides a broad outpatient MRI portfolio alongside its PET work, consistent with a diagnostic imaging center focused on oncology and cross-sectional imaging.
Revenue concentration is extreme for both payers: the provider’s top three Medicare codes account for 76.9% of its Medicare revenue, driven mainly by A9596, 78815 and A9552; on the Medicaid side the top three codes account for 89.0% of Medicaid revenue, dominated by 78815, A9552 and 73721. This level of concentration indicates the practice’s financial performance is closely tied to a narrow set of high-cost imaging and radiopharmaceutical services rather than a diversified mix of low-revenue procedures.
Scale and payer mix: HONOLULU IMAGING CENTER, LLC reports $2.6M in total Medicare revenue versus $1.1M in total Medicaid revenue, so Medicare is the larger single payer by reported dollars. Both payers are meaningful to the practice’s overall book of business, but Medicare represents the majority of recorded revenue.
National competitive standing on Medicare for key radiopharmaceuticals is pronounced: A9596 ranks #2 of 168 providers nationally (99th percentile) and is labeled an "extreme outlier," marking this provider as a national leader in billing for Gallium Ga-68 gozetotide; 78815 ranks #151 of 6566 (98th percentile) and A9552 ranks #72 of 2411 (97th percentile), both described as "notably above typical" national volumes and supporting a top-tier national footprint for PET services. These rank/percentile positions suggest unusually high Medicare activity for specific PET-related services compared with peers.
Medicaid competitive picture is mixed and more localized: 78815 generates 53.2% of the provider’s Medicaid revenue (802 claims, $607.1K revenue) but ranks only #4 of 5 in-state (25th percentile; "typical, unremarkable volume"), while A9552 (786 claims, $249.9K revenue) ranks #3 of 5 in-state (50th percentile). Conversely, 73721 contributes 14.0% of Medicaid revenue and ranks #3 of 15 in-state (86th percentile), indicating stronger relative standing in some MRI joint imaging lines within state peers.
Unique in-state activity for certain radiotracers: the provider appears to be the sole in-state reporter for A9596 on Medicaid (13 claims, $25.8K revenue; rank #1 of 1 providers in-state with "no state peer volume comparison available"), which suggests a service or supply capability local peers are not reporting for this specific Ga-68 agent. That uniqueness on Medicaid, paired with national leadership for the same code on Medicare, highlights a specialized capability in Ga-68 PET imaging.
Outlier MRI angiography activity on Medicare: the code 70544 (MR angiography of the head without contrast) shows 168 claims and $31.2K revenue and is labeled an "extreme outlier" (rank #33 of 4160, 99th percentile). This indicates an unusually high Medicare volume for cranial MRA relative to national peers and suggests the center performs a higher-than-typical caseload of vascular brain imaging in addition to PET services.
Tenure and operational maturity: the NPI was enumerated on 2021-07-10 (~5 years ago), so the provider’s recorded Medicare and Medicaid billing history spans roughly a five-year operational window under the current NPI. Observed billing patterns — particularly concentrated high-volume PET/radiopharmaceutical claims and selected MRI outlier codes — appear established within that period rather than being a single short-term spike.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
58 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| A9596 | Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | 1,170 | $830 | $968.6K |
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 590 | $1,340 | $783.3K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 470 | $430 | $203.3K |
| 78816 | The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The… | 60 | $1,350 | $86.5K |
| 70553 | In this procedure, the provider performs a magnetic resonance imaging, or MRI, study of the brain including the brain stem. He performs this procedure without using contrast material. He then follows… | 280 | $270 | $77.5K |
| 78812 | PET scans are highly effective in the detection of cancerous cells in the body. A PET scan provides a three–dimensional image of the body that makes it easy to detect the presence of a malignant… | 40 | $1,340 | $48.2K |
| 72197 | In this diagnostic procedure, the provider performs magnetic resonance imaging (MRI) of the pelvis first without using contrast and again after injecting contrast material. | 210 | $220 | $44.7K |
| 72148 | In this diagnostic procedure, the provider performs magnetic resonance imaging (MRI) of the lumbar spinal canal and contents without using contrast. | 290 | $150 | $43.6K |
| 73221 | In this diagnostic procedure, the provider performs a magnetic resonance imaging, or MRI imaging, of any of the joints of a patient’s upper extremity, which can be the shoulder, elbow, wrist, or… | 270 | $160 | $42.2K |
| 70551 | The provider uses magnetic resonance imaging, or MRI, to examine the brain and brain stem. The provider does not administer contrast for this exam. | 210 | $160 | $33.4K |
Showing 1–10 of 58
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 58 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
11 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 800 | $760 | $607.1K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 790 | $320 | $249.9K |
| 73721 | In this diagnostic procedure, the provider performs magnetic resonance imaging of a lower extremity joint without using contrast material. | 610 | $260 | $159.4K |
| 70553 | In this procedure, the provider performs a magnetic resonance imaging, or MRI, study of the brain including the brain stem. He performs this procedure without using contrast material. He then follows… | 140 | $410 | $56K |
| 73221 | In this diagnostic procedure, the provider performs a magnetic resonance imaging, or MRI imaging, of any of the joints of a patient’s upper extremity, which can be the shoulder, elbow, wrist, or… | 130 | $220 | $27.5K |
| A9596 | Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | 10 | $1,980 | $25.8K |
| 72148 | In this diagnostic procedure, the provider performs magnetic resonance imaging (MRI) of the lumbar spinal canal and contents without using contrast. | 90 | $160 | $13.9K |
| 71046 | In this diagnostic procedure, the provider performs a minimum of two radiological views of the chest. He performs this study for the assessment of conditions affecting the chest, its contents, and… | 70 | $20 | $1.2K |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 90 | $10 | $750 |
| 76705 | An abdominal ultrasound is a noninvasive procedure used to assess the body parts within the abdomen (i.e. liver, gallbladder, pancreas, bile ducts, spleen, and abdominal aorta). This particular code… | 20 | $40 | $650 |
Showing 1–10 of 11
How this provider's Medicaid billing volume and revenue compare to other Hawaii providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Hawaii median
11 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 4 | 10 | 870 | $780 | $981.5K |
| 70553 | In this procedure, the provider performs a magnetic resonance imaging, or MRI, study of the brain including the brain stem. He performs this procedure without using contrast material. He then follows… | 7 | 10 | 130 | $410 | $218.1K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 3 | 10 | 790 | $120 | $105.7K |
| 73721 | In this diagnostic procedure, the provider performs magnetic resonance imaging of a lower extremity joint without using contrast material. | 3 | 20 | 110 | $240 | $74.8K |
| 71046 | In this diagnostic procedure, the provider performs a minimum of two radiological views of the chest. He performs this study for the assessment of conditions affecting the chest, its contents, and… | 46 | 50 | 1,250 | $10 | $60.5K |
| 72148 | In this diagnostic procedure, the provider performs magnetic resonance imaging (MRI) of the lumbar spinal canal and contents without using contrast. | 6 | 10 | 90 | $200 | $58.9K |
| 76705 | An abdominal ultrasound is a noninvasive procedure used to assess the body parts within the abdomen (i.e. liver, gallbladder, pancreas, bile ducts, spleen, and abdominal aorta). This particular code… | 21 | 20 | 880 | $30 | $45.3K |
| 73221 | In this diagnostic procedure, the provider performs a magnetic resonance imaging, or MRI imaging, of any of the joints of a patient’s upper extremity, which can be the shoulder, elbow, wrist, or… | 2 | 10 | 50 | $240 | $31.1K |
| A9596 | Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | 1 | 10 | 10 | $1,980 | $25.8K |
| S9999 | Sales tax | 179 | 240 | 200 | $1 | $820 |
Showing 1–10 of 11
Other providers in the same ZIP code as Honolulu Imaging Center, LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Walgreen Co | HI | Pharmacy | $0 | $25.3M |
| Mastercare Inc | HI | Nursing Care Agency | $0 | $10.8M |
| Attention Plus Private Nursing, Inc. | HI | Nursing Care Agency | $0 | $7.7M |
| Heaven's Helpers, Inc. | HI | In Home Supportive Care Agency | $0 | $4.5M |
| Heaven's Helpers, Inc. | HI | Nursing Care Agency | $0 | $4M |
| Eugene W M Ng Md LLC | HI | Ophthalmology Physician | $0 | $3.7M |
| Bayada Home Care | HI | In Home Supportive Care Agency | $0 | $3.6M |
| B Homecare L.L.C. | HI | In Home Supportive Care Agency | $0 | $3.5M |
| Hawaii Diagnostic Radiology Services LLC | HI | Diagnostic Radiology Physician | $0 | $3.2M |
| Dean T. Sueda Dds.ms, Inc | HI | Pediatric Dentistry | $0 | $3.1M |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.